Edition:
United Kingdom

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

171.98USD
6:45pm GMT
Change (% chg)

$0.98 (+0.57%)
Prev Close
$171.00
Open
$171.58
Day's High
$172.13
Day's Low
$171.08
Volume
21,528
Avg. Vol
167,129
52-wk High
$172.43
52-wk Low
$128.01

Select another date:

BRIEF-Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​

* Labcorp - Co,‍ Capital Health announced that they have entered into a laboratory partnership​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Diagnostics power LabCorp's beat-and-raise quarter

Laboratory Corp of America Holdings' profit topped analysts' estimates and the company raised its full-year revenue growth forecast on Wednesday, expecting growth from its diagnostics business.

UPDATE 2-Diagnostics power LabCorp's beat-and-raise quarter

Oct 25 Laboratory Corp of America Holdings' profit topped analysts' estimates and the company raised its full-year revenue growth forecast on Wednesday, expecting growth from its diagnostics business.

LabCorp posts marginal rise in quarterly profit

Oct 25 Laboratory Corp of America Holdings reported a marginal rise in quarterly profit, helped by higher demand for its diagnostic services, even as costs rose.

BRIEF-Interpace Diagnostics announces renewal and extension of LabCorp national agreement

* Interpace Diagnostics announces renewal and extension of LabCorp national agreement

BRIEF-Chromadex sells its analytical testing business to LabCorp

* Chromadex sells its analytical testing business to LabCorp, to accelerate the expansion of Nicotinamide Riboside and its other patented ingredient technologies

BRIEF-LabCorp announces proposed sale of senior notes

Aug 15 Laboratory Corporation Of America Holdings:

Select another date: